老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Can-Fite Biopharma Ltd

1.13
+0.08508.17%
成交量：5.74万
成交额：6.21万
市值：1,445.97万
市盈率：-1.04
高：1.13
开：1.07
低：1.05
收：1.04
数据加载中...
总览公司新闻公告
2020/03/27

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/05

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/27

非美公司披露报告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/24

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/20

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/11

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
更多